Sustained metabolic control in latent autoimmune diabetes in adults (LADA) with semaglutide therapy in a patient with multiple autoimmune comorbidities: a case report and literature review.

A single-patient case report describing durable glycemic control, weight loss, and preserved beta-cell function over five years on semaglutide in latent autoimmune diabetes (LADA). The authors' own literature review turned up only two comparable case reports, so this is genuinely novel but carries the weight any single anecdote does: no control, no causal claim. Useful color on an under-studied indication, but readers should not generalize from one patient.